AI-Discovered Lung Disease Drug Enters Phase III Trials in China
96Stats · x · 2026-07-14
A lung disease drug entirely discovered by AI has officially entered Phase III clinical trials in China.\n\nReports indicate that AI handled the entire R&D process for this drug, from identifying disease targets to designing the drug molecules. Currently, 320 名患者 are participating in the trial to verify its actual efficacy, which has shown positive therapeutic potential in earlier stages.
Related event: AI-Discovered Drug Enters Phase III Trials in China(2 posts)→
More from Research
- LoMa Paper Ships REALLY HardPairs Dataset, Accepted at ECCV 2026 — ducha_aiki · 2026-09-11
- Johns Hopkins Launches Full-Stack Hands-on Robot Learning Class with SO-101 Arm Kits — _krishna_murthy · 2026-09-11
- SyncWorld: In-Context Robot World Model Simulates Unseen Views and Embodiments Zero-Shot — ChongZzZhang · 2026-09-11
- A 3D Pose Dataset for Dogs Released — ducha_aiki · 2026-09-11
- Five tells that still make AI video read as AI, from physics glitches to missing operators — NewPhoneWhotiz · 2026-09-11
- AnyMatch accepted to ECCV 2026 with a NoPresenter design — ducha_aiki · 2026-09-11